Home > Share Market > Stocks > Aurobindo pharma > Financial Statements> AUROPHARMA Profit & Loss

Aurobindo Pharma Ltd Financial Statements

Profit & Loss Statement of Aurobindo Pharma Ltd

  • Tabular Data
  • Graph
  • Consolidated
  • Standalone
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 Mar-2018 Mar-2017
Revenue 24,775 23,099 16,463 14,910
yoy growth (%) 7.26 40.30 10.40 8.08
Raw materials (9,902) (9,735) (6,753) (6,434)
As % of sales 40 42.10 41 43.20
Employee costs (3,535) (3,219) (2,131) (1,768)
As % of sales 14.30 13.90 12.90 11.90
Other costs (6,004) (5,280) (3,808) (3,273)
As % of sales 24.20 22.90 23.10 22
Operating profit 5,333 4,864 3,772 3,434
OPM 21.50 21.10 22.90 23
Depreciation (1,055) (967) (558) (428)
Interest expense (74) (305) (78) (67)
Other income 381 192 105 116
Profit before tax 4,584 3,784 3,241 3,056
Taxes (2,010) (914) (818) (760)
Tax rate (44) (24) (25) (25)
Minorities and other 1.02 1.45 0.26 0.47
Adj. profit 2,576 2,872 2,423 2,297
Exceptional items 2,815 (26) -- --
Net profit 5,335 2,831 2,423 2,302
yoy growth (%) 88.40 16.80 5.28 13.70
NPM 21.50 12.30 14.70 15.40

Invest in at ZERO Delivery Brokerage. Join 22 Lac+ Happy Clients